These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38282038)

  • 41. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
    Suárez-Reyes A; Villegas-Valverde CA
    MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
    Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
    J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis.
    Mahumud RA; Kamara JK; Renzaho AMN
    Infection; 2020 Dec; 48(6):813-833. PubMed ID: 32813220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study.
    Abayomi A; Osibogun A; Kanma-Okafor O; Idris J; Bowale A; Wright O; Adebayo B; Balogun M; Ogboye S; Adeseun R; Abdus-Salam I; Mutiu B; Saka B; Lajide D; Yenyi S; Agbolagorite R; Onasanya O; Erinosho E; Obasanya J; Adejumo O; Adesola S; Oshodi Y; Akase IE; Ogunbiyi S; Omosun A; Erinoso F; Abdur-Razzaq H; Osa N; Akinroye K
    Glob Health Res Policy; 2021 Jul; 6(1):26. PubMed ID: 34325747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 and liver disease: mechanistic and clinical perspectives.
    Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic.
    Ahmed S; Gasparyan AY; Zimba O
    Rheumatol Int; 2021 Feb; 41(2):243-256. PubMed ID: 33388969
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
    Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
    Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
    Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
    Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study.
    Sang S; Sun R; Coquet J; Carmichael H; Seto T; Hernandez-Boussard T
    J Med Internet Res; 2021 Feb; 23(2):e23026. PubMed ID: 33534724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preexisting comorbidities shape the immune response associated with severe COVID-19.
    Kreutmair S; Kauffmann M; Unger S; Ingelfinger F; Núñez NG; Alberti C; De Feo D; Krishnarajah S; Friebel E; Ulutekin C; Babaei S; Gaborit B; Lutz M; Jurado NP; Malek NP; Göpel S; Rosenberger P; Häberle HA; Ayoub I; Al-Hajj S; Claassen M; Liblau R; Martin-Blondel G; Bitzer M; Roquilly A; Becher B
    J Allergy Clin Immunol; 2022 Aug; 150(2):312-324. PubMed ID: 35716951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel disease syndromes unveiled by integrative multiscale network analysis of diseases sharing molecular effectors and comorbidities.
    Li H; Fan J; Vitali F; Berghout J; Aberasturi D; Li J; Wilson L; Chiu W; Pumarejo M; Han J; Kenost C; Koripella PC; Pouladi N; Billheimer D; Bedrick EJ; Lussier YA
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):112. PubMed ID: 30598089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip.
    Kumar M; Gulati S; Ansari AH; Phutela R; Acharya S; Azhar M; Murthy J; Kathpalia P; Kanakan A; Maurya R; Vasudevan JS; S A; Pandey R; Maiti S; Chakraborty D
    Elife; 2021 Jun; 10():. PubMed ID: 34106048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. THE VALUE OF A REGIONAL 'LIVING' COVID-19 REGISTRY AND THE CHALLENGES OF KEEPING IT ALIVE.
    Hanna J; Chen T; Portales-Castillo C; Said M; Bulnes R; Newhart D; Sienk L; Schantz K; Rozzi K; Alag K; Bress J; Lesho DO E
    Perspect Health Inf Manag; 2021; 18(3):1d. PubMed ID: 34858116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
    Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Artificial Intelligence in the Fight Against COVID-19: Scoping Review.
    Abd-Alrazaq A; Alajlani M; Alhuwail D; Schneider J; Al-Kuwari S; Shah Z; Hamdi M; Househ M
    J Med Internet Res; 2020 Dec; 22(12):e20756. PubMed ID: 33284779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenetic profiling of COVID-19 and SARS-like viruses.
    Nain Z; Rana HK; Liò P; Islam SMS; Summers MA; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1175-1196. PubMed ID: 32778874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comorbidities of COVID-19 Patients.
    Silaghi-Dumitrescu R; Patrascu I; Lehene M; Bercea I
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.
    Panda M; Kalita E; Singh S; Kumar K; Rao A; Prajapati VK
    Life Sci; 2022 Sep; 305():120761. PubMed ID: 35787998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.